非突变卵巢癌特异性抗原的免疫性
Leslie Hesnard1, Catherine Thériault1, Maxime Cahuzac1
1Institute for Research in Immunology and Cancer (IRIC), University of Montreal, Montreal, QC H3T 1J4, Canada.
Current oncology (Toronto, Ont.)
|June 26, 2024
概括
新的研究发现瘤特异性抗原 (TSAs) 是上皮卵巢癌 (EOC) 免疫治疗的有希望的标. 这些抗原可以有效地刺激CD8 T细胞,为癌症治疗提供了一条新的途径.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 蛋白质基因组学是什么
背景情况:
- 表面卵巢癌 (EOC) 由于缺乏确定的可采取行动的点,目前的免疫疗法取得了有限的成功.
- 之前的蛋白质基因组分析在EOC中确定了91种瘤特异性抗原 (TSA),通常由于表观遗传变化而来自非外来区域.
研究的目的:
- 为了评估48个选定的TSAs的免疫性,用于潜在的EOC免疫疗法.
- 评估树突细胞的TSA表现及其刺激CD8T细胞的能力.
主要方法:
- 向质谱测量用于量化树突细胞上的TSA呈现.
- 用TSA脉冲的树突细胞刺激原始的CD8 T细胞.
- 使用MHC-四聚合物染色和TCR Vβ CDR3测序对T细胞扩张的评估.
主要成果:
- 合成的TSA被树突细胞有效地呈现出来.
- TSA的丰度与预测对人类白细胞抗原 (HLA) 全型的结合 afinity 相关联.
- TSAs成功地扩大了显著的CD8 T细胞种群.
结论:
- 研究的TSA证明了免疫性和EOC免疫疗法的潜力.
- 这些TSA代表了开发新型卵巢癌治疗的可行目标.
相关概念视频
Antigens Involved in Adaptive Immunity
483
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
483
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
Cancer Vaccines
351
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
351
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K


